Fukabori Yoshitatsu, Yoshida Ken-Ichiro, Nakano Katsuya, Shibata Yasuhiro, Yamanaka Hidetoshi, Oyama Tetsunari
Department of Urology, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan.
J Urol. 2006 Sep;176(3):1204-7. doi: 10.1016/j.juro.2006.04.028.
When a prostate needle biopsy specimen is used for molecular study, a second specimen from the same area as the first one has previously been required for pathological diagnosis. However, we developed a method for obtaining substances such as RNA and we also made pathological diagnosis possible from a single needle biopsy specimen, improving reliability.
Prostate needle biopsy specimens from 118 patients were frozen in optimal cutting temperature compound. Tissue from the upper part of the frozen specimen was sectioned longitudinally for histopathological examination. The remainder of the specimen was placed in TRIzol reagent to extract total RNA for molecular biological investigation.
Pathological diagnosis and total RNA extraction (1.6 to 32.7 microg) could be obtained from 1 needle biopsy specimen. When 2 specimens were obtained from the same area of the prostate, pathological diagnoses were discordant in 19% of the cases.
We established a method for histopathological diagnosis in the prostate needle biopsy specimen used for molecular investigation. This single specimen method may facilitate molecular research in prostate cancer.
当前列腺穿刺活检标本用于分子研究时,此前需要从与第一个标本相同的区域获取第二个标本用于病理诊断。然而,我们开发了一种获取RNA等物质的方法,并且还能够从单个穿刺活检标本进行病理诊断,提高了可靠性。
将118例患者的前列腺穿刺活检标本置于最佳切割温度化合物中冷冻。将冷冻标本上部的组织纵向切片用于组织病理学检查。将标本的其余部分置于TRIzol试剂中以提取总RNA用于分子生物学研究。
从1个穿刺活检标本中可同时获得病理诊断和总RNA提取(1.6至32.7微克)。当从前列腺同一区域获取2个标本时,19%的病例病理诊断不一致。
我们建立了一种用于分子研究的前列腺穿刺活检标本的组织病理学诊断方法。这种单标本方法可能会促进前列腺癌的分子研究。